Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I heard the Pestell Prostagen deal was a Tony C brainchild tha Nader was always suspicious of and opposed but the BOD forced it.
No mention of COVID on the Advancingll.com site. I wonder if this means they would stop all of the COVID trials? Could that be an issue for Brazil and Philippines and India? Is this why things seem to have slowed?
The golden goose isn’t laying enough golden eggs fast enough so now everyone wants to catch it and extract more eggs faster. In the fairy tale by that name they killed the goose. The lawsuits, the hostile takeover group all serve the same purpose, to delay or prevent getting Leronlimab to market. Cydy has manufacturing and distribution and some good clinical results but more data is needed. We’ve gone to Brazil for those trials, why the delays in ANVISA approval? Is there corruption in Brazil? What does Biomm say about the process, is this normal response when so many Brazilians are dying that they can’t move more quickly on a life-saving medication like Leronlimab?
Testing the 50 DMA with bollinger bands pinching inward, now we just need the MACD to turn up
Share price says it’s a non-event.
Forget the 13D gypsies. Let’s get some action on the Brazil trials and start reversing the tragedy happening now in Latin America.
Maybe in a week or so, 3 weeks after Jun 21 cc according to what was said it would be in an 8K with data.
Interesting Twitter thread:
It has taken me a week to gather thoughts & put together a thread on what happened to my husband and I last week.
— Nicole L. Stout DPT, FAPTA (@NicoleStoutPT) June 29, 2021
The message is important, it is one of awareness and practical vigilance. The choices we made at the time were logical based on our current vaccinated status…BUT 1/
Refuse to File letter from FDA pertaining to HIV biologic license application for Leronlimab.
https://trialsitenews.com/pfizers-tofacitinib-helps-covid-19-patients-with-pneumonia-in-phase-2-study-in-partnership-with-hospital-israelita-albert-einstein-in-brazil/ I certainly hope our trials move forward soon in Brazil. Phizer’s trial is. I hope ANVISA is not as corrupt as the US FDA.
I don’t understand why Brazil has slipped from June to July. Why the delays?
Thank you for that post!
Dr. Bruce Patterson @brucep13 will be live on this channel in about an hour. https://t.co/eaRamgAWHm
— Dr. Mobeen Syed (@drbeen_medical) June 25, 2021
She is still on the company web site in “team”. Her LinkedIn has been that way for a while.
I notice that Arian Colaches has removed Cytodyn from her LinkedIn profile. https://www.linkedin.com/in/ariancolachis
She is still shown as part of the team in the Cytodyn web site.
Tweet from the pioneer of MRNA vaccines about Leronlimab:
Good news for COVID-19 long hauler syndrome sufferors.https://t.co/wiyIO70ZfC
— Robert W Malone, MD (@RWMaloneMD) June 22, 2021
Thanks for that JBL! Folks need to stop the FUD! Phillipines and Brazil and India are sovereign nations with their own regulations.
I hope you are right. We are also discussing regulatory advancements.
NP had Patterson advising him for a while. Did he listen? Does he listen to Recknor? Did he listen to Rahman?
Courtesy of Chris Lonsford on Facebook:
History Lesson: Where does Dr Allen fit into the history of CytoDyn? (Posted on another group). Thought it was worth sharing!
Where does Allen D. Allen fit in to this inventor's puzzle? Allen was most curious when it was discovered that the AIDS virus infected chimps, but did not make them sick. Why was AIDS killing humans? How was the human immune system
different?
In the same way that a composer creates a song or a software engineer designs an application, Allen wondered if one could modify the human immune system to solve this problem. He began to realize that a monoclonal antibody (MAB) could change the immune system so that it would stop "helping" the AIDS virus.
The future of medicine is full of hope, theory and opinion. AIDS was, and is, a frightening epidemic and the hysteric reaction of social and political forces were creating great pressure on the medical community that was grasping at straws to find a solution. New theories and treatments were proposed, tested and often failed. New drugs were creating dangerous side effects and even killing patients. Often doctors think in a herd-like mentality. At the time, most experts believed that a MAB antibody could never be used as a treatment.
Fred Chris was a gay man with AIDS and a friend of Allen Allen. He became the first to receive a monoclonal antibody. The results were instantaneous. Symptoms, such as skin lesions, vanished overnight and his T-cell count climbed. The damage, born of the AIDS virus, was halted.
A second, third and fourth patient were treated. The results were miraculously the same. On the West coast, word began to spread among the desperate AIDS doctors. The doctors treated two to three hundred patients with the antibody. Data from 188 patients were eventually submitted to the FDA. Unlike most other AIDS treatments, there were no serious side effects and no one was dying from it.
The elation that Allen felt was soon deflated. Armed with his data, he approached pharmaceutical companies and venture capitalists to launch a study. The expert medical opinion believed that a monoclonal antibody could not be used as treatment. Allen was kicked to the curb.
The patients who had been successfully treated and their friends and family conferred with Allen. They created and funded a privately held company, designed to launch a formal clinical trial. With approximately thirty-five shareholders and his eldest daughter Corinne, who had become a CPA, CytoDyn, Inc. was born.
The UK has warned the US 3 times. We're 1 for 2 so far.
— Eric Topol (@EricTopol) June 19, 2021
1. Covid is coming. Response: "It won't happen here" X
2. Alpha variant. Response: Solid vaccination campaign, a bump instead of a surge ✓
3. Delta variant. Response is lacking any sense of urgency to date pic.twitter.com/uUjRm4QVMQ
They call it Leronlimabe
Interesting that Gottleib is working for Phizer now. If I’m not mistaken, thrombocyopenia is a side effect of both the vaccines and COVID sometimes and Leronlimab is an antidote.
Short interest=39.2 million shares. Most heavily shorted OTC stock. https://www.reddit.com/r/CYDY/comments/o22l87/top_otcqb_shorted_guess_what_cydy_is_the_most/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
Thanks for posting. I sure hope you are right.
Why haven’t they started in Brazil?
Yes, to the point of being laughable. These emergent diseases in India are horrible. Is Leronlimab the answer, the cure to these tragedies? https://www.dailymail.co.uk/news/article-9658675/India-battles-surge-cases-rare-deadly-inflammatory-syndrome-striking-children.html
You can’t prove that.